157 related articles for article (PubMed ID: 30256702)
1. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
[TBL] [Abstract][Full Text] [Related]
2. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren's syndrome.
Liuqing W; Liping X; Hui S; Jing L
J Investig Med; 2017 Mar; 65(3):717-721. PubMed ID: 28057714
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
[TBL] [Abstract][Full Text] [Related]
4. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
5. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
6. [Serum IL-21 level in patients with primary Sjogren's syndrome and clinical significance of IL-21].
Yuan SL; Jiang L; Zhang XL; Li SF; Duan HM; Wang XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):124-6. PubMed ID: 17286904
[TBL] [Abstract][Full Text] [Related]
7. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
9. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
11. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
12. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
[TBL] [Abstract][Full Text] [Related]
13. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
15. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
[TBL] [Abstract][Full Text] [Related]
16. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of progranulin correlated with serum soluble Oxford 40 ligand in primary Sjögren's syndrome.
Qi X; Guo H; Sun C; Tian Y; Ding M; Yang Y; Jin H
Medicine (Baltimore); 2020 May; 99(18):e19967. PubMed ID: 32358369
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis.
Zhang LW; Zhou PR; Wei P; Cong X; Wu LL; Hua H
Scand J Immunol; 2018 Apr; 87(4):e12649. PubMed ID: 29476557
[TBL] [Abstract][Full Text] [Related]
19. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.
Miletic M; Stojanovic R; Pajic O; Bugarski D; Mojsilovic S; Cokic V; Milenkovic P
Indian J Med Res; 2012 Apr; 135(4):513-9. PubMed ID: 22664499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]